Aleta Biotherapeutics and Cancer Research UK's Centre for Drug Development Announce First Patient Dosed in ...

NATICK, Mass. & LONDON--(BUSINESS WIRE)--Aleta Biotherapeutics and Cancer Research UK’s Centre for Drug Development Announce First Patient Dosed in ALETA-001 Phase 1/2 Clinical Trial ...

Related Keywords

United Kingdom ,Aleta Biotherapeutics , ,Cancer Research United Kingdom ,Drug Development Announce First Patient Dosed ,Businesswire Health Kbusinesswire Kbusinesswireen Notfrontpage Pressrelease ,